| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| EGCG | Hepatitis B | 3 | PM | 37122751 | 📋 | Inhibition of macrophages inflammasome activation via autophagic degradation of HMGB1 by EGCG ameliorates HBV-induced liver injury and fibrosis |
| EGCG | Hepatitis B | 2 | PM | 26968537 | 📋 | Epigallocatechin Gallate Inhibits Hepatitis B Virus via Farnesoid X Receptor Alpha |
| EGCG | Hepatitis B | 1 | PM | 25996297 | 📋 | Epigallocatechin-3-gallate Opposes HBV-induced Incomplete Autophagy by Enhancing Lysosomal Acidification, Which Is Unfavorable for HBV Replication |
| EGCG | Hepatitis C | 2 | PM | 30949812 | 📋 | Epigallocatechin Gallate (EGCG) and miR-548m Reduce HCV Entry Through Repression of CD81 Receptor in HCV Cell Models |
| EGCG | Hepatitis C | 1 | PM | 26202241 | 📋 | Polyphenols Inhibit Hepatitis C Virus Entry by a New Mechanism of Action |
